IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
42 hedge funds and large institutions have $4.51M invested in ImmunoCellular Therapeutics, Ltd. in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less call options, than puts
Call options by funds: $121K | Put options by funds: $139K
Holders
42
Holding in Top 10
–
Calls
$121K
Puts
$139K
Top Buyers
| 1 | +$363K | |
| 2 | +$234K | |
| 3 | +$121K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$56K |
| 5 |
Citigroup
New York
|
+$29.4K |
Top Sellers
| 1 | -$691K | |
| 2 | -$32.9K | |
| 3 | -$11.3K | |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$9.68K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.5K |